TABLE 1.
Models | miRNAs | Expression | Tissue | Target gene | References |
pSNL | miR-23a-3p | ↓ | Spinal glial cells | CXCR4 TXNIP/NLRP3 | Pan et al., 2018 |
CCI | miR-381 | ↑ | Spinal cord tissues | HMGB1/CXCR4 | Zhan et al., 2018 |
SNL | miR-186-5P | ↓ | Spinal astrocyte | CXCL13 | Jiang et al., 2016 |
SNL | miR-103 | ↓ | Spinal cord | Cav1.2-LTC | Favereaux et al., 2011 |
SNL | miR-17-92 | ↑ | DRG | Voltage-gated potassium channel | Sakai et al., 2017 |
SNL | miR-7a | ↓ | DRG | Voltage-gated sodium channel | Sakai et al., 2013 |
SNL | miR-30b | ↓ | DRG/spinal cord | Voltage-gated sodium channel Nav1.3 | Su et al., 2017 |
NP patients | miR-124a, miR-155 | ↑ | Blood samples | SIRT1 | Heyn et al., 2016 |
SNL | miR-183 | ↓ | L5 DRG | T-Cell intracellular antigen 1 (TIA-1) | Aldrich et al., 2009 |
SNL | miR-21, miR-431, miR-511-3p | ↑ | DRG | IL-6 | Hori et al., 2016 |
CCI | miR-146a-5p | ↑ | DRG/SDH | IRAK1/TRAF6 | Wang Z. et al., 2018 |
SNL | miR-146a-5p | ↑ | Spinal cord | TRAF6/JNK | Lu et al., 2015 |
SCI | miR-218 | ↓ | Spinal cord | SOCS3/p-P38 | Li and Zhao, 2016 |
CCI | miR-221 | ↑ | Spinal cord | SOCS1 | Xia et al., 2016 |
CCI + tolerance morphine | miR-223 | ↓ | Spinal cord | NLRP3 | Xie X.J. et al., 2017 |
CCI | miR-34c | ↓ | Spinal cord | NLRP3 | Xu et al., 2019 |
CCI | miR-26a-5p | ↓ | Spinal cord | MAPK6 | Zhang et al., 2018a |
CCI | miR-1 | ↓ | SN/DRG | Cx43/BDNF | Neumann et al., 2015 |
SNI | miR-30c-5p | ↑ | Spinal cord/DRG/plasma/fluid cerebrospinal | BAMBI | Tramullas et al., 2018 |
DNP | miR-190a-5p | ↓ | Spinal dorsal horn | SLC17A6 | Yang et al., 2017 |
DNP | miR-193a | ↓ | Spinal dorsal horn | HMGB1 | Wu B. et al., 2019 |
DNP | miR-221 | ↑ | Serum | SOCS3 | Wu et al., 2021 |
DPNP | miR-590-3p | ↓ | DRG/T cells | RAP1A | Wu et al., 2020 |
SCI | miR-130a-3p | ↑ | Spinal cord | IGF-1/IGF-1R | Yao et al., 2021 |
CCI | miR-378 | ↓ | Spinal cord | EZH2 | Gao et al., 2021 |
pSNL | miR-138 | ↑ | Spinal cord | TLR4 MIP-1a/CCR1 | Jin et al., 2021 |
CCI | miR-223 | ↓ | Spinal cord | NLRP3/IL-1β | Zhu et al., 2021 |
CCI | miR-122-5p | ↓ | Spinal cord | PDK4 | Wan et al., 2021 |
CCI | miR-142-3p | ↑ | Sciatic nerve | cAMP/AMPK | Li et al., 2021 |
NP patients/SNI | miR-132-3p | ↑ | White blood cells/SN/DRG/Spinal cord | GluA1/GluA2 | Leinders et al., 2016 |
CCI | miR-200b/miR-429 | ↑ | Microglia from the Spinal cord | ZEB1 | Yan et al., 2018c |
SNI | CREB-miR-132 | ↓ | Spinal cord | MeCP2 | Zhang et al., 2015 |
CCI | miR-183 | ↓ | Spinal cord horn | mTOR/VEGF | Xie X. et al., 2017 |
Oxaliplatin-induced NP | miR-30b-5p | ↓ | DRG | Nav1.6 | Li L. et al., 2019 |
Oxaliplatin-induced NP | miR-15b | ↑ | DRG | BACE1 | Ito et al., 2017 |
L5 ventral root transection/paclitaxel-induced NP | miR-500 | ↑ | Spinal cord horn | GAD67 | Huang et al., 2016 |
SCI | miR-23b | ↓ | Spinal cord | NOX4 | Im et al., 2012 |
CCI | miR-183 | ↓ | Spinal cord horn | MAP3K4/IL-6/IL-1β/COX2 | Huang et al., 2020 |
SNI | miR-21 | ↑ | DRG | TLR8 | Zhang et al., 2018c |
NP, Neuropathic pain; DRG, dorsal root ganglion; pSNL, partial sciatic nerve ligation; SNL, sciatic nerve ligation; SNI, spared nerve injury; CCI, chronic constriction injury; SCI, spinal cord injury; DNP, diabetic neuropathic pain; CXCR4, chemokine CXC receptor 4; TXNIP, thioredoxin-interacting protein; NLRP3, NOD-like receptor protein 3; HMGB1, high-mobility group box 1 protein; CXCL13, C–X–C motif chemokine 13; Cav1.2-LTC, L-type calcium channel; SIRT1, sirtuin1; SDH, spinal dorsal horn; IRAK1, inhibiting interleukin-1 receptor-associated kinase 1; TRAF6, tumor necrosis factor receptor-associated factor 6; SOCS3, suppressor of cytokine signaling 3; SN, sciatic nerve; BDNF, brain-derived neurotrophic factor; Cx43, connexin 43; BAMBI, bone morphogenetic protein and membrane-bound inhibitor; ZEB1, zinc finger E box binding protein-1; MeCP2, methyl CpG-binding protein 2; NOX4, NADPH oxidase 4; TLR8, toll-like receptor 8; IL-1β, interleukin-1β; PDK4, pyruvate dehydrogenase kinase 4; RAP1A, Ras-associated protein 1A; SLC17A6, [solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6]; MIP-1α, macrophage inflammatory protein-1 alpha and CCR1, C–C chemokine receptor type 1; AMPK, AMP-activated protein kinase; EZH2, enhancer of zeste homolog 2; BACE1, β-site amyloid precursor protein-cleaving enzyme 1.